Multiple endpoint analysis of BAC-preserved and unpreserved antiallergic eye drops on a 3D-reconstituted corneal epithelial model

Molecular Vision

Volumn 17, Issue , 2011, Pages 745-755

  Pauly, A ^a,b,c   Brasnu, E ^a,b,c,d   Riancho, L ^a,b,c   Brignole Baudouin, F ^a,b,c,e   Baudouin, C ^a,b,c,d,f  

^a INSTITUT DE LA VISION   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c CNRS   (France)

^d CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^e Department of Toxicology   (France)

^f LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BENZALKONIUM CHLORIDE; CROMOGLYCATE DISODIUM; DNA NUCLEOTIDYLEXOTRANSFERASE; EPINASTINE; EYE DROPS; INTERCELLULAR ADHESION MOLECULE 1; KETOTIFEN; KETOTIFEN FUMARATE; KI 67 ANTIGEN; LEVOCABASTINE; N ACETYLASPARTYLGLUTAMIC ACID; NAABAK; OCCLUDIN; OLOPATADINE; PHOSPHATE BUFFERED SALINE; UNCLASSIFIED DRUG; ZALERG;

APOPTOSIS; ARTICLE; BASEMENT MEMBRANE; CELL DAMAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORNEA EPITHELIUM; DRUG EFFECT; DRUG FORMULATION; DRUG SCREENING; EPITHELIOID CELL; EYE ALLERGY; FLUORESCENCE MICROSCOPY; FROZEN SECTION; INCUBATION TIME; MEMBRANE MODEL; MEMBRANE RECONSTITUTION; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THREE DIMENSIONAL IMAGING; TIGHT JUNCTION;

ANTI-ALLERGIC AGENTS; APOPTOSIS; BENZALKONIUM COMPOUNDS; BIOLOGICAL MARKERS; CELL PROLIFERATION; CELL SURVIVAL; ENDPOINT DETERMINATION; EPITHELIUM, CORNEAL; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IN SITU NICK-END LABELING; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; KI-67 ANTIGEN; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MODELS, BIOLOGICAL; OPHTHALMIC SOLUTIONS; PRESERVATIVES, PHARMACEUTICAL; TIGHT JUNCTIONS;

EID: 79952834609     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Martín AP, Urrets-Zavalia J, Berra A, Mariani AL, Gallino N, Gomez Demel E, Gagliardi J, Baena-Cagnani CE, Urrets-Zavalia E, Serra HM. The effect of ketotifen on inflammatory markers in allergic conjunctivitis: an open, uncontrolled study. BMC Ophthalmol 2003; 3:2. [PMID: 12515585]
2. Schoch C. Effects of ketotifen 0.025% and lodoxamide 0.1% on eosinophil infiltration into the guinea pig conjunctiva in a model of allergic conjunctivitis. J Ocul Pharmacol Ther 2003; 19:153-9. [PMID: 12804060]
3. Borazan M, Karalezli A, Akova YA, Akman A, Kiyici H, Erbek SS. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. Acta Ophthalmol 2009; 87:549-54. [PMID: 18631332]
4. Avunduk AM, Tekelioglu Y, Turk A, Akyol N. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial. Clin Ther 2005; 27:1392-402. [PMID: 16291412]
5. Kidd M, McKenzie SH, Steven I, Cooper C, Lanz R. Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis. Br J Ophthalmol 2003; 87:1206-11. [PMID: 14507747]
6. Ganz M, Koll E, Gausche J, Detjen P, Orfan N. Ketotifen fumarate and olopatadine hydrochloride in the treatment of allergic conjunctivitis: a real-world comparison of efficacy and ocular comfort. Adv Ther 2003; 20:79-91. [PMID: 12836808]
7. Bielory L, Friedlaender MH. Allergic conjunctivitis. Immunol Allergy Clin North Am 2008; 28:43-58. [PMID: 18282545]
8. Wong AH, Barg SS, Leung AK. Seasonal and perennial allergic conjunctivitis. Recent Pat Inflamm Allergy Drug Discov 2009; 3:118-27. [PMID: 19519588]
9. Baudouin C, Labbe A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res 2010; 29:312-34. [PMID: 20302969]
10. Baudouin C, Liang H, Hamard P, Riancho L, Creuzot-Garcher C, Warnet JM, Brignole-Baudouin F. The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology 2008; 115:109-15. [PMID: 17532048]
11. Brasnu E, Brignole-Baudouin F, Riancho L, Guenoun JM, Warnet JM, Baudouin C. In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line. Curr Eye Res 2008; 33:303-12. [PMID: 18398704]
12. Baudouin C, Riancho L, Warnet JM, Brignole F. In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost. Invest Ophthalmol Vis Sci 2007; 48:4123-8. [PMID: 17724196]
13. Liang H, Baudouin C, Pauly A, Brignole-Baudouin F. Conjunctival and corneal reactions in rabbits following short-and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride. Br J Ophthalmol 2008; 92:1275-82. [PMID: 18723745]
14. Guenoun JM, Baudouin C, Rat P, Pauly A, Warnet JM, Brignole-Baudouin F. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci 2005; 46:2444-50. [PMID: 15980234]
15. Ichijima H, Petroll WM, Jester JV, Cavanagh HD. Confocal microscopic studies of living rabbit cornea treated with benzalkonium chloride. Cornea 1992; 11:221-5. [PMID: 1587129]
16. Ishibashi T, Yokoi N, Kinoshita S. Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride. J Glaucoma 2003; 12:486-90. [PMID: 14646684]
17. Buron N, Micheau O, Cathelin S, Lafontaine PO, Creuzot-Garcher C, Solary E. Differential mechanisms of conjunctival cell death induction by ultraviolet irradiation and benzalkonium chloride. Invest Ophthalmol Vis Sci 2006; 47:4221-30. [PMID: 17003409]
18. Epstein SP, Ahdoot M, Marcus E, Asbell PA. Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells. J Ocul Pharmacol Ther 2009; 25:113-9. [PMID: 19284328]
19. Martone G, Frezzotti P, Tosi GM, Traversi C, Mittica V, Malandrini A, Pichierri P, Balestrazzi A, Motolese PA, Motolese I, Motolese E. An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology. Am J Ophthalmol 2009; 147:725-35. [PMID: 19181302]
20. Rolando M, Brezzo V, Giordano G, Campagna P, Burlando S, Calabria G. The effect of different benzalkonium chloride concentrations on human normal ocular surface. In: Van Bijsterveld O, Lemp M, Spinelli D, editors. The Lacrimal System. Amsterdam, Berkely, Milano: Kugler and Ghedini Publications; 1991.
21. Baudouin C, Hamard P, Liang H, Creuzot-Garcher C, Bensoussan L, Brignole F. Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term. Ophthalmology 2004; 111:2186-92. [PMID: 15582072]
22. Calonge M, Diebold Y, Saez V, Enriquez de Salamanca A, Garcia-Vazquez C, Corrales RM, Herreras JM. Impression cytology of the ocular surface: a review. Exp Eye Res 2004; 78:457-72. [PMID: 15106925]
23. Schwab IR, Linberg JV, Gioia VM, Benson WH, Chao GM. Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications. Ophthalmology 1992; 99:197-202. [PMID: 1348114]
24. Broadway D, Grierson I, Hitchings R. Adverse effects of topical antiglaucomatous medications on the conjunctiva. Br J Ophthalmol 1993; 77:590-6. [PMID: 8218059]
25. Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol 1994; 112:1446-54. [PMID: 7980134]
26. Doucet O, Lanvin M, Thillou C, Linossier C, Pupat C, Merlin B, Zastrow L. Reconstituted human corneal epithelium: a new alternative to the Draize eye test for the assessment of the eye irritation potential of chemicals and cosmetic products. Toxicol In Vitro 2006; 20:499-512. [PMID: 16243479]
27. Meloni M, Pauly A, Servi BD, Varlet BL, Baudouin C. Occludin gene expression as an early in vitro sign for mild eye irritation assessment. Toxicol In Vitro 2010; 24:276-85. [PMID: 19729060]
28. Pauly A, Meloni M, Brignole-Baudouin F, Warnet JM, Baudouin C. Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage. Invest Ophthalmol Vis Sci 2009; 50:1644-52. [PMID: 19168896]
29. Liang H, Pauly A, Riancho L, Baudouin C, Brignole-Baudouin F. Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogs on a 3D-reconstituted corneal epithelium system. Br J Ophthalmol. 2010 In press
30. Manciocco A, Chiarotti F, Vitale A, Calamandrei G, Laviola G, Alleva E. The application of Russell and Burch 3R principle in rodent models of neurodegenerative disease: the case of Parkinson's disease. Neurosci Biobehav Rev 2009; 33:18-32. [PMID: 18771685]
31. ECVAM Technical Report on the Status of Alternative Methods for Cosmetics Testing (2008-2009). A report prepared in the framework of Directive 2003/15/EC (7th Amendment to the Cosmetics Directive): Publications Office of the European Union; 2010.
32. Nguyen DH, Beuerman RW, De Wever B, Rosdy M. Alternative Toxicological Methods. Salem H, Katz S, Editors: CRC Press; 2003. p. 147-59.
33. Kahn CR, Young E, Lee IH, Rhim JS. Human corneal epithelial primary cultures and cell lines with extended life span: in vitro model for ocular studies. Invest Ophthalmol Vis Sci 1993; 34:3429-41. [PMID: 7693609]
34. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996; 84:345-57. [PMID: 8608588]
35. Wang Y, Chen M, Wolosin JM. ZO-1 in corneal epithelium; stratal distribution and synthesis induction by outer cell removal. Exp Eye Res 1993; 57:283-92. [PMID: 8224016]
36. Langbein L, Grund C, Kuhn C, Praetzel S, Kartenbeck J, Brandner JM, Moll I, Franke WW. Tight junctions and compositionally related junctional structures in mammalian stratified epithelia and cell cultures derived therefrom. Eur J Cell Biol 2002; 81:419-35. [PMID: 12234014]
37. Ban Y, Dota A, Cooper LJ, Fullwood NJ, Nakamura T, Tsuzuki M, Mochida C, Kinoshita S. Tight junction-related protein expression and distribution in human corneal epithelium. Exp Eye Res 2003; 76:663-9. [PMID: 12742348]
38. Baudouin C. Allergic reaction to topical eyedrops. Curr Opin Allergy Clin Immunol 2005; 5:459-63. [PMID: 16131924]
39. Sosnová-Netuková M, Kuchynka P, Forrester JV. The suprabasal layer of corneal epithelial cells represents the major barrier site to the passive movement of small molecules and trafficking leukocytes. Br J Ophthalmol 2007; 91:372-8. [PMID: 17020902]
40. Chuang EY, Li DQ, Bian F, Zheng X, Pflugfelder SC. Effects of contact lens multipurpose solutions on human corneal epithelial survival and barrier function. Eye Contact Lens 2008; 34:281-6. [PMID: 18779668]
41. Manners T. Managing eye conditions in general practice. BMJ 1997; 315:816-7. [PMID: 9345194]
42. Owen CG, Shah A, Henshaw K, Smeeth L, Sheikh A. Topical treatments for seasonal allergic conjunctivitis: systematic review and meta-analysis of efficacy and effectiveness. Br J Gen Pract 2004; 54:451-6. [PMID: 15186569]
43. Abelson MB. A review of olopatadine for the treatment of ocular allergy. Expert Opin Pharmacother 2004; 5:1979-94. [PMID: 15330735]
44. Ciprandi G, Cosentino C, Milanese M, Tosca MA. Rapid anti-inflammatory action of azelastine eyedrops for ongoing allergic reactions. Ann Allergy Asthma Immunol 2003; 90:434-8. [PMID: 12722967]
45. Yanni JM, Weimer LK, Sharif NA, Xu SX, Gamache DA, Spellman JM. Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs. Arch Ophthalmol 1999; 117:643-7. [PMID: 10326962]
46. Fisher AA. Allergic contact dermatitis and conjunctivitis from benzalkonium chloride. Cutis 1987; 39:381-3. [PMID: 3581909]
47. Baudouin C, Garcher C, Haouat N, Bron A, Gastaud P. Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma. Ophthalmology 1994; 101:454-60. [PMID: 7907416]
48. De Saint Jean M, Baudouin C, Di Nolfo M, Roman S, Lozato P, Warnet JM, Brignole F. Comparison of morphological and functional characteristics of primary-cultured human conjunctival epithelium and of Wong-Kilbourne derivative of Chang conjunctival cell line. Exp Eye Res 2004; 78:257-74. [PMID: 14729358]
49. Debbasch C, Brignole F, Pisella PJ, Warnet JM, Rat P, Baudouin C. Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells. Invest Ophthalmol Vis Sci 2001; 42:642-52. [PMID: 11222522]
50. Becquet F, Goldschild M, Moldovan MS, Ettaiche M, Gastaud P, Baudouin C. Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. Curr Eye Res 1998; 17:419-25. [PMID: 9561834]
51. Baudouin C, Pisella PJ, Fillacier K, Goldschild M, Becquet F, De Saint Jean M, Bechetoille A. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 1999; 106:556-63. [PMID: 10080214]
52. Mietz H, Niesen U, Krieglstein GK. The effect of preservatives and antiglaucomatous medication on the histopathology of the conjunctiva. Graefes Arch Clin Exp Ophthalmol 1994; 232:561-5. [PMID: 7959096]
53. Pauly A, Brignole-Baudouin F, Guenoun JM, Riancho L, Rat P, Warnet JM, Baudouin C. Comparative study of topical antiallergic eye drops on human conjunctiva-derived cells: responses to histamine and IFN gamma and toxicological profiles. Graefes Arch Clin Exp Ophthalmol 2007; 245:534-46. [PMID: 16900358]
54. Ayaki M, Iwasawa A, Yaguchi S, Koide R. Preserved and unpreserved 12 anti-allergic ophthalmic solutions and ocular surface toxicity: in vitro assessment in four cultured corneal and conjunctival epithelial cell lines. Biocontrol Sci 2010; 15:143-8. [PMID: 21212507]